Kodiak Sciences Inc.

PALO ALTO, CA · Founded 2009 · CIK 0001468748 · Biotech · Public

Biologic therapeutics for retinal diseases, delivered via intravitreal injection

kodiak.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$36M
2 Form D · Mar 2016
127 months since last filing
Contracts
—
No federal contracts on record
Patents
40
14 granted · 26 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,836,044
Private capital raisedForm D · SEC$33,960,000
Form D · SECPress

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1205ADIAL PHARMACEUTICALS, INC.—$38M
1206FORWARD DEFENSE, LLC——
1207Gigagen, Inc.—$36M
1208Kodiak Sciences Inc.—$36M
1209MIRNATECH INTERNATIONAL, INC.——
1210VIVASC THERAPEUTICS INC——
1211AUGMENTA BIOWORKS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Press

1 article · matched on company name

Founders & Team

From Form D filings · 3 related persons
  • John BorgesonExecutive Officer
  • Steven CharlesDirector · Executive Officer
  • Victor PerlrothDirector · Executive Officer

Patents

USPTO · 14 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.